A randomized, double‐blind, placebo‐controlled, parallel‐group 12‐week pilot phase II trial of SaiLuoTong (SLT) for cognitive function in older adults with mild cognitive impairment
Article in Alzheimer's & Dementia: Translational Research & Clinical Interventions (October 2023)